120 related articles for article (PubMed ID: 8057524)
1. Electrophysiologic interaction between class I antiarrhythmic drugs and volatile anesthetics in depressant effects on ventricular activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
Jpn J Pharmacol; 1994 Apr; 64(4):235-41. PubMed ID: 8057524
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction between class I antiarrhythmic drugs and halothane in depressant effects on ventricular activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
Biol Pharm Bull; 1994 Mar; 17(3):449-53. PubMed ID: 8019516
[TBL] [Abstract][Full Text] [Related]
3. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
4. Coupling interval-related effects of class I antiarrhythmic drugs, mexiletine, cibenzoline and disopyramide, on ventricular activation in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
Jpn J Pharmacol; 1991 Dec; 57(4):463-72. PubMed ID: 1803064
[TBL] [Abstract][Full Text] [Related]
5. Selective effects of tocainide in canine acute myocardial infarction.
Hiromasa S; Li ZY; Coto H; Maldonado C; Kupersmith J
Int J Cardiol; 1990 Apr; 27(1):79-86. PubMed ID: 2110552
[TBL] [Abstract][Full Text] [Related]
6. Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium.
Hashimoto H; Satoh N; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):683-90. PubMed ID: 2096300
[TBL] [Abstract][Full Text] [Related]
7. Comparison of electrophysiologic and hemodynamic effects of SD-3212, a new antiarrhythmic drug, and flecainide in a canine myocardial infarction model.
Hashimoto H; Umemura K; Araki S; Ishii M; Nagashima S; Uematsu T; Nakashima M
Biol Pharm Bull; 1994 Apr; 17(4):548-50. PubMed ID: 8069268
[TBL] [Abstract][Full Text] [Related]
8. Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction.
Deutsch N; Hantler CB; Tait AR; Uprichard A; Schork MA; Knight PR
Anesthesiology; 1990 Jun; 72(6):1012-21. PubMed ID: 2350016
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction.
de Langen CD; Hanich RF; Michelson EL; Kadish AH; Levine JH; Balke CW; Spear JF; Moore EN
J Am Coll Cardiol; 1988 Feb; 11(2):403-13. PubMed ID: 3339181
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of pirmenol and lidocaine on intraventricular conduction in canine myocardial infarction.
Hashimoto H; Ozaki T; Nagashima S; Nakashima M
J Electrocardiol; 1991 Oct; 24(4):379-85. PubMed ID: 1744550
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects of volatile anesthetics, sevoflurane and halothane, in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
J Anesth; 1994 Mar; 8(1):93-100. PubMed ID: 28921208
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects of bepridil in normal and infarcted canine myocardium.
Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR
J Cardiovasc Pharmacol; 1986; 8(5):957-66. PubMed ID: 2429097
[TBL] [Abstract][Full Text] [Related]
14. Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
Ogawa S; Mitamura H; Katoh H
Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():621-6. PubMed ID: 8251432
[TBL] [Abstract][Full Text] [Related]
15. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
[TBL] [Abstract][Full Text] [Related]
16. Slow antegrade excitation and delayed retrograde activation through an "inexcitable zone": A basis for arrhythmia formation in infarcted myocardium ex vivo.
Patterson E; Scherlag BJ
J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1213-1222. PubMed ID: 28570022
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous anesthetics, thiopental, fentanyl, and morphine on ventricular delayed activation in a canine myocardial infarction model.
Hashimoto H; Imamura S; Ikeda K; Nakashima M
Biol Pharm Bull; 1993 Dec; 16(12):1226-30. PubMed ID: 8130771
[TBL] [Abstract][Full Text] [Related]
19. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction.
Hashimoto H; Katoh H; Nakashima M
J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695
[TBL] [Abstract][Full Text] [Related]
20. Effects of class I drugs on reentrant ventricular tachycardia in a canine model of myocardial infarction: on their antiarrhythmic and proarrhythmic mechanisms.
Miyazaki T; Ogawa S; Sakai T; Hosokawa M; Sakurai K; Nakamura Y
Jpn Circ J; 1988 Mar; 52(3):254-61. PubMed ID: 3373717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
